The Senate judiciary committee has postponed a Nov. 30 hearing on the proposed settlement between Mylan and the U.S. Justice Department over the EpiPen after Mylan and the government refused to participate.
The committee is considering rescheduling the hearing with witness subpoenas, according to committee chairman Sen. Chuck Grassley.
Mr. Grassley, R-Iowa, had called the hearing to examine the proposed deal amid criticism that the $465 million settlement was not harsh enough. Mylan announced the preliminary deal in early October, resolving complaints that the company was overcharging Medicaid for the EpiPen allergy shot by misclassifying it as a generic instead of a brand name product.
“Their decision to duck appropriate scrutiny will not stop this committee’s pursuit for answers,” Mr. Grassley said in a statement Wednesday.
“We now must consider compelling their participation.”
Mylan has its operational base in Cecil.
Patricia Sabatini: PSabatini@post-gazette.com; 412-263-3066.





Comments
Welcome to Post-Gazette subscriber-only commenting community. Please review our community guidelines.